Myriad supports your population health initiatives with affordable, best-in-class hereditary cancer testing and reproductive precision screening supported by scalable patient education, cost transparency, staff training, and integration guidance. We can help your organization prioritize preventative care and patient outcomes through actionable, genetic insights that inform treatment decisions for the women in your care throughout their health journey, from pre-pregnancy to post-menopause.
eBookRethinking the role of genetic testing in women’s health programsRead now
ENHANCE CLINICAL EFFICACY
Identify more high-risk women with screening and genetic testing during regularly scheduled appointments.
Offer on-demand, personalized education to help patients see the value in testing right away.
Navigate high-risk patients to appropriate preventative services such as: High Risk Consults, Breast MRIs, and Prophylactic Surgeries.
Infographic7 ways a hereditary cancer risk assessment program can identify more women for precision careRead now
VideoClinicians on Programmatic Hereditary Cancer Risk AssessmentWatch
Myriad works with systems like yours to help develop program workflows, integrate ordering within your EMR, provide ongoing staff training, enable patient screening, streamline patient payment details, and educate patients before and after the test.
Pre-visit screener in patient portalDigital screening with MyGeneHistory® based on medical society guidelines
Pre-test genetic educationPatient education video and telehealth session with a board-certified genetic counselor at no cost
Simple MyRisk® test orderingOnline portal and RIS/EMR integration
Personalized cost estimatesFinancial assistance for those that qualify
Actionable resultsEasy to use MyRisk® Management Tool and personalized Tyrer-Cuzick/RiskScore® when applicable
Post-test genetic consultsBoard certified genetic counselors available M-F for individualized results support for patients and providers
Care management plan developmentCircle of care referrals
Streamline CLINICAL WORKFLOWS
Women at risk of hereditary cancer and those looking for information about their future or current pregnancy deserve a genetic testing approach that doesn’t leave anyone out, regardless of their ancestry or BMI. But to deliver, your health system needs a genetic testing provider that puts patients first with a scalable approach that is simple, streamlined, and integrates into your clinical workflow and EMR with user-friendly ordering and results.
ArticlesModernizing Genetic Counseling in Women’s Health Programs: Enhancing Clinical Workflows While Reducing Provider BurdenRead now
The Clinical Impact of Myriad Women’s Health Hereditary Cancer Genetic Testing and Prenatal ScreeningRead now
Together, we can identify how to implement a program that works in your health system — and supports your commitment to the best care.
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Contact Information
case study
A multi-state health system’s hereditary cancer risk assessment program began with one clinician recognizing an opportunity to improve patients’ lives and the quality of care at her clinic. It became the framework for identifying and treating the women in their care who are at high-risk for hereditary cancer. Read how they did it.
“Affecting communities at the population health level can make lasting changes for generations to come. Moving away from a one-size-fits-all approach to cancer risk assessment and management improves quality of care and patient satisfaction.”
An OB/GYN at a multi-state health system
patients screened
eligible for genetic testing
tests reported
eligible for breast MRI (TCv8)
pathogenic mutations found
medical procedures selected for 6,369 patients
Health systems need to reduce the cost of healthcare without sacrificing quality. A programmatic approach to women’s hereditary cancer risk assessment can help.
spent on breast cancer care in the first two years following early stage diagnosis2
vs.
spent on breast cancer care in first two years following late stage diagnosis2
According to a review of public data, 36% of Americans have at least one first-degree relative with cancer. Yet, a 2022 Myriad survey revealed that 30% of women don’t know whether their family has a history of cancer.
Genetic tests aren’t all the same. Learn why you need to consider accuracy, scientific rigor, and service offerings when deciding on which tests to use.
Genetic testing isn’t just about the results. Risk assessment, education, and counseling are also required. Learn how to identify testing labs that align with your value-based care goals.
Ancestry and BMI can sometimes make it difficult to get accurate genetic test results for pregnant women. Learn what to look for in prenatal testing.
View all